Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 218.12% | -27.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 218.12% | -27.28% | |||
| Cost of Revenue | 24.14% | 416.63% | |||
| Gross Profit | 4.62% | -276.52% | |||
| SG&A Expenses | 51.20% | -69.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.93% | 0.82% | |||
| Operating Income | -17.38% | -4.45% | |||
| Income Before Tax | 164.28% | 7.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 164.28% | 7.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 164.28% | 7.20% | |||
| EBIT | -17.38% | -4.45% | |||
| EBITDA | -16.73% | -4.19% | |||
| EPS Basic | 163.90% | 7.66% | |||
| Normalized Basic EPS | -17.43% | -8.38% | |||
| EPS Diluted | 91.39% | 7.69% | |||
| Normalized Diluted EPS | 30.44% | -8.38% | |||
| Average Basic Shares Outstanding | 0.60% | 0.49% | |||
| Average Diluted Shares Outstanding | 69.84% | 0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||